Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-14 10:50 am Purchase | 2025-03-31 | 13G | 10x Genomics, Inc. TXG | ARK Investment Management LLC | 12,845,713 11.870% | 1,488,702 (+13.11%) | Filing History |
| 2025-05-12 1:58 pm Sale | 2025-03-31 | 13G | 10x Genomics, Inc. TXG | Nikko Asset Management Americas, Inc. | 5,362,656 5.000% | -1,010,556 (-15.86%) | Filing History |
| 2025-05-07 10:55 am Sale | 2025-04-30 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 5,647,993 5.200% | -9,035,879 (-61.54%) | Filing History |
| 2025-05-07 10:40 am Sale | 2025-03-31 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 14,683,872 13.000% | -3,047,397 (-17.19%) | Filing History |
| 2025-04-25 06:22 am Sale | 2025-03-31 | 13G | 10x Genomics, Inc. TXG | Sumitomo Mitsui Trust Group Inc. | 5,363,366 5.000% | -1,009,846 (-15.85%) | Filing History |
| 2025-04-04 4:00 pm Purchase | 2025-04-01 | 13G | 10x Genomics, Inc. TXG | Millennium Management LLC | 5,533,618 5.100% | 5,533,618 (New Position) | Filing History |
| 2024-11-08 2:46 pm Purchase | 2024-09-30 | 13G | 10x Genomics, Inc. TXG | Nikko Asset Management Americas, Inc. | 6,373,212 5.980% | 6,373,212 (New Position) | Filing History |
| 2024-11-05 06:07 am Purchase | 2024-09-30 | 13G | 10x Genomics, Inc. TXG | Sumitomo Mitsui Trust Group Inc. | 6,373,212 5.980% | 6,373,212 (New Position) | Filing History |
| 2024-10-04 2:14 pm Purchase | 2024-09-30 | 13G | 10x Genomics, Inc. TXG | The Vanguard Group | 10,972,930 10.300% | 1,961,598 (+21.77%) | Filing History |
| 2024-08-12 11:16 am Purchase | 2024-07-31 | 13G | 10x Genomics, Inc. TXG | ARK Investment Management LLC | 11,357,011 10.750% | 11,357,011 (New Position) | Filing History |
| 2024-06-07 09:55 am Purchase | 2024-05-31 | 13G | 10x Genomics, Inc. TXG | BAILLIE GIFFORD & CO | 2,777,115 2.630% | 2,777,115 (New Position) | Filing History |
| 2024-02-13 4:55 pm Purchase | 2023-12-29 | 13G | 10x Genomics, Inc. TXG | The Vanguard Group | 9,011,332 8.650% | 591,321 (+7.02%) | Filing History |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 17,731,269 16.252% | 4,683,939 (+35.90%) | Filing History |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | 10x Genomics, Inc. TXG | BlackRock Inc. BLK | 5,705,051 5.500% | 385,872 (+7.25%) | Filing History |
| 2024-01-29 11:43 am Sale | 2023-12-29 | 13G | 10x Genomics, Inc. TXG | BAILLIE GIFFORD & CO | 7,919,976 7.600% | -682,259 (-7.93%) | Filing History |
| 2023-12-08 4:37 pm Sale | 2023-11-30 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 3,630,398 3.500% | -1,509,063 (-29.36%) | Filing History |
| 2023-07-10 4:38 pm Sale | 2023-06-30 | 13G | 10x Genomics, Inc. TXG | MORGAN STANLEY MS | 5,139,461 5.200% | -4,755,518 (-48.06%) | Filing History |
| 2023-07-10 10:20 am Purchase | 2023-07-07 | 13G | 10x Genomics, Inc. TXG | FMR LLC | 13,047,330 12.658% | 4,154,232 (+46.71%) | Filing History |
| 2023-02-14 4:05 pm Unchanged | 2022-12-31 | 13G | 10x Genomics, Inc. TXG | Venrock Associates VI L.P. | 4,828,247 4.900% | 0 (Unchanged) | Filing History |
| 2023-02-09 10:54 am Purchase | 2022-12-30 | 13G | 10x Genomics, Inc. TXG | The Vanguard Group | 8,420,011 8.810% | 865,969 (+11.46%) | Filing History |